Keratolytics can replace curettage in daylight photodynamic therapy for actinic keratosis on the face/scalp: A randomized clinical trial.

Caccavale S, Boccellino MP, Brancaccio G, Alfano R, Argenziano G. Keratolytics can replace curettage in daylight photodynamic therapy for actinic keratosis on the face/scalp: A randomized clinical trial. J Eur Acad Dermatol Venereol. 2024 Mar; 38(3):594-601.

View in: PubMed

subject areas

Curettage
Humans
Keratolytic Agents
Keratosis, Actinic
Pain
Photochemotherapy
Photosensitizing Agents
Scalp

authors with profiles

Robert R. Alfano

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support